To discover the potential targets of BC, we intersected the prognostic regulators with the CNV-related differential genes and identified a hub regulator, YTHDF1, which is highly expressed in BC and cluster1 (immune inactivated cluster), and is classified as a ‘reader’ that recognises, binds, and promotes the translation efficiency of m6A17,21. Here, YTHDF1 is linked to breast cancer.